Bimekizumab, a humanised monoclonal antibody, is the first and only dual inhibitor of IL-17A and IL-17F, two pro-inflammatory ...
Background: Acute disseminated encephalomyelitis (ADEM) is a rare demyelinating disease of the central nervous system usually ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results